Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and ZolgensmaFrederick W. Thielen, Carin A. Uyl‐de Groot, Renaud Heine et al.|Cytotherapy|2022Cited by 26
Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived TherapiesNatividad Cuende, Gabriel C. Oniscu, Stefan G. Tullius et al.|Transplantation|2024Cited by 12
What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal InsufficiencySejad Ayyoubi, Frederick W. Thielen, Hugo van der Kuy et al.|PharmacoEconomics - Open|2024Cited by 8